Solasta Ventures Asset Manager Profile - aVenture Research
Solasta Ventures is a healthcare and life sciences investment firm focused on advancing the standard of care for diseases with unmet medical needs. As a wholly-owned subsidiary of Aju IB Investment, a leading South Korean venture capital firm, Solasta Ventures targets innovative therapeutics and discovery platforms. The firm typically invests in Series A through Series D rounds, with significant involvement in Series B and C stages.
Notable portfolio companies include Atea Pharmaceuticals, Kymera Therapeutics, and Carisma Therapeutics. The firm is led by key decision-makers with deep scientific expertise and extensive networks. Solasta Ventures offers unique value-add services such as leveraging scientific knowledge and strategic partnerships to support the growth and success of their portfolio companies.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.